Comments on ‘Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond’ by M. J. Pencina et al., Statistics in Medicine (DOI: 10.1002/sim.2929)

This publication has 10 references indexed in Scilit:

• Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond
  Statistics in Medicine, 2007
• Role of the Apolipoprotein B–Apolipoprotein A-I Ratio in Cardiovascular Risk Assessment: A Case–Control Analysis in EPIC-Norfolk
  Annals of Internal Medicine, 2007
• Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction
  Circulation, 2007
• Development and Validation of Improved Algorithms for the Assessment of Global Cardiovascular Risk in Women
  JAMA, 2007
• The Effect of Including C-Reactive Protein in Cardiovascular Risk Prediction Models for Women
  Annals of Internal Medicine, 2006
• Comparing the predictive values of diagnostic tests: sample size and analysis for paired study designs
  Clinical Trials, 2006
• A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women
  New England Journal of Medicine, 2005
• Limitations of the Odds Ratio in Gauging the Performance of a Diagnostic, Prognostic, or Screening Marker
  American Journal of Epidemiology, 2004
• Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
  JAMA, 2001
• A COMPARISON OF GOODNESS-OF-FIT TESTS FOR THE LOGISTIC REGRESSION MODEL
  Statistics in Medicine, 1997